Functionalized Core-Shell Nanogel for Dual LPS and Cytokine Scavenging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for sepsis, a life-threatening hyperinflammatory syndrome, have unacceptably high mortality rates due to the lack of effective methods for simultaneously neutralizing lipopolysaccharides (LPS) and cytokines, which trigger systemic inflammation.

Innovation Solution

A biomolecule-binding nanogel composition comprising crosslinked hydrogel nanoparticles with dendritic telodendrimers functionalized with hydrophobic and charged moieties, polymerized with a PEG chain, is developed to selectively capture LPS and cytokines, providing a size-exclusive network for effective immune modulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If cationic amphiphilic small molecules, peptides, and antibodies are used for LPS attenuation, then LPS binding capability is improved, but mortality reduction efficacy is insufficient

Engineering Contradiction:
ImproveLPS binding capabilityVSAvoidmortality reduction efficacy
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent combines LPS binding capability with cytokine scavenging capability into a single nanogel system. The nanogel simultaneously binds LPS through its amphiphilic structure and scavenges cytokines through its porous network, achieving dual functionality that resolves the insufficiency of single-function therapies in reducing mortality

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The nanogel is constructed as a composite material with specific hydrophobic and hydrophilic domains. The hydrophobic regions bind LPS while the hydrophilic porous network traps cytokines, creating a composite structure that achieves both LPS attenuation and cytokine removal for improved mortality reduction efficacy

Inventive Principle:
Principle #40Composite materials

2Quantity of substance

If anti-cytokine therapies are used, then cytokine levels are reduced, but simultaneous LPS attenuation is not achieved

Engineering Contradiction:
Improvecytokine levelsVSAvoidsimultaneous LPS attenuation capability
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The nanogel is designed as a universal therapeutic agent that performs multiple functions: it scavenges cytokines through its porous structure and simultaneously binds LPS through its amphiphilic moieties. This multi-functional design allows a single therapy to address both cytokine overload and LPS presence, achieving versatility that single-function anti-cytokine therapies lack

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Object-affected harmful factors

If conventional LPS-attenuating therapies are used, then LPS neutralization is achieved, but cytokine removal is not accomplished

Engineering Contradiction:
ImproveLPS neutralizationVSAvoidcytokine removal capability
Core Design Contradiction:
Object-affected harmful factorsVSAdaptability or versatility

Solution Approach 1:

The nanogel merges LPS neutralization function with cytokine removal function into a single therapeutic system. The amphiphilic structure provides LPS binding while the porous network enables cytokine trapping, creating a dual-function therapy that simultaneously addresses both harmful factors without requiring separate treatments

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The nanogel effectively attenuates NF-κB activation and cytokine production in septic mouse models, improving survival rates and reducing systemic inflammation by scavenging LPS and cytokines, demonstrating potential as a novel therapeutic modality for sepsis treatment.

Implementation Method 1

dendritic functionalized telodendrimer containing a plurality of hydrophobic groups and hydrophilic charged binding moieties

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 2

hydrophilic charged binding moieties

Methodology Applied
Scientific EffectElectrostatic attraction: Ion Repulsion/Attraction

Implementation Method 3

the linear polyethylene glycol polymer (PEG) chain extending on the surface of the nanoparticle to protect a size-exclusive nanogel network

Methodology Applied
Scientific EffectSteric protection:

Implementation Method 4

nano-sized crosslinked hydrogel system... to protect a size-exclusive nanogel network

Methodology Applied
Scientific EffectSize exclusion:

Data Source

PatentUS20250205360A1Functionalized core-shell nanogel scavenger for immune modulation therapy
Publication Date: 2025.06.26 THE RES FOUNDATION FOR THE STATE UNIV OF NEW YORK
  • US20250205360A1 patent drawing
  • US20250205360A1 patent drawing
  • US20250205360A1 patent drawing

AI summary

Sepsis is a life-threatening complication of host response to infection and tissue damages. It is characterized by the uncontrolled systemic inflammatory response. Immune modulation therapy hasn't demonstrated consistent benefit in the clinic, due to the dynamic, complex, and heterogenous immune response in sepsis. Spontaneous attenuation of a broad spectrum of septic molecules and cytokines is promising for effective sepsis treatment. Embodiments disclosed herein are directed to functionalized nano-sized hydrogel, i.e., nanogel (NG), via a one-pot precipitation polymerization using biocompatible, biodegradable monomers/crosslinkers and versatile polymerizable hybrid telodendrimer (TD) nanotraps (NTs) for effective septic molecules scavenging.